Healthy volunteers test new drug epaminurad in Early-Stage safety study
NCT ID NCT07374406
First seen Jan 31, 2026 · Last updated May 24, 2026 · Updated 13 times
Summary
This early-stage study looked at how safe a new drug called epaminurad is and how it moves through the body. It involved 34 healthy adults who took a single dose of the drug while fasting. The goal was to measure drug levels in the blood, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Jeonbuk National University Hospital
Jeonju, South Korea
Conditions
Explore the condition pages connected to this study.